Relay Therapeutics, Inc. RLAY Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax?
- Relay Therapeutics, Inc. (RLAY) reported other comprehensive income unrealized holding gain loss on securities arising during period before tax of -$172K in Q1 2026.
- How has Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax changed year-over-year?
- Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax decreased by 116.7% year-over-year, from $1.03M to -$172K.
- What is the long-term trend for Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax has grown at a 10.6% compound annual growth rate (CAGR), from -$1.15M to $1.72M.
- What does other comprehensive income unrealized holding gain loss on securities arising during period before tax mean?
- This metric measures the change in the fair value of investment securities held by the company that have not yet been sold. It captures market-driven fluctuations in the value of the company's investment portfolio before tax considerations. This provides insight into the performance of the company's treasury management and the unrealized gains or losses on its liquid assets.